Need help choosing the right code?
Ask CasePilot about procedures, modifiers, bundling, and coding guidance.
Try CasePilotLast Updated: January 2026 | Verified for 2026 AMA, CPT & CMS Guidelines
This guide focuses on the compliance points that most often determine payment: (1) documentation and CLIA elements that prove the test is a valid waived laboratory service; (2) diagnosis coding and coverage criteria for Medicare and commercial payers; (3) bundling rules (especially PET-related edits); and (4) how to use modifiers when the same patient has multiple glucose measurements on the same day.
CPT 82962 is defined as “Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use.” It represents a quantitative glucose value produced by a point-of-care device, typically using capillary blood from a fingerstick. The defining feature is the device category (home-use-cleared meter), not the patient setting. Coding authorities and payer policies repeatedly treat 82962 as appropriate for office/clinic testing when the clinic uses that kind of device .
Typical clinical scenarios include:
Because 82962 is a clinical laboratory service, payment depends on (a) medical necessity and (b) laboratory compliance elements. The documentation standard is straightforward: a reviewer must be able to see why the test was ordered, that it was performed, and what the result was.
The clinic must hold an appropriate CLIA certificate for the complexity level of the testing performed; for waived glucose meter testing, that generally means a CLIA Certificate of Waiver. Claims frequently deny when the CLIA number is missing or mismatched. Many payer guidance documents emphasize that the diagnosis on the claim must support medical necessity and that laboratory services are subject to coverage rules and frequency review .
Medicare often requires modifier QW to identify waived tests. However, CMS publishes a list of codes that are recognized as waived without appending QW, and 82962 is included on that list. CMS’s MLN guidance states these codes “don’t require a QW modifier to be recognized as a waived test” . This means Medicare systems can recognize 82962 as a waived-service code without QW, assuming the CLIA elements are present.
Operational best practice: Even though QW is not required by Medicare for 82962, confirm whether a specific commercial payer’s claims edits expect QW across all waived tests. Some payer policies explicitly discuss how waived tests are handled and may apply their own formatting rules .
Diagnosis coding is the most common driver of denials for office glucose tests. Many payers only reimburse 82962 when linked to a covered indication. Medicare’s NCD 190.20 provides the national framework for when blood glucose testing is reasonable and necessary, including diabetes, suspected hypo/hyperglycemia, and other conditions that affect glucose metabolism .
In day-to-day billing, the most common ICD-10 groupings are:
Medicare covers diagnostic glucose testing when it is reasonable and necessary under NCD 190.20. The NCD’s language supports glucose testing for diabetes and related clinical circumstances and also discusses reasonable frequency patterns, including a commonly cited example: for stable diabetic patients not self-testing, periodic clinic testing such as quarterly monitoring may be reasonable. The policy also implies that unusually frequent testing should be justified by clinical changes, therapy adjustments, or unstable disease .
Separately, Medicare Administrative Contractors may publish billing and coding articles emphasizing that claims must include appropriate ICD-10 codes and that frequency of laboratory services is subject to review. These articles often function as practical enforcement documents: they remind providers that absent a covered diagnosis, testing is not medically necessary and may require an ABN for beneficiary liability .
Medicare’s diabetes screening benefit is distinct from diagnostic testing. Screening coverage rules define eligibility (risk factors, prediabetes) and frequency. NIDDK’s professional guidance summarizes how Medicare expects screening claims to be coded and which CPT codes are typically used for the benefit . Importantly, screening coverage frequently relies on laboratory-based glucose codes (for example fasting plasma glucose or glucose tolerance testing). If a clinic uses a fingerstick meter for screening and bills 82962 with Z13.1, payment can be inconsistent because Medicare’s screening frameworks commonly emphasize lab-based codes and specific billing conventions . When a screening fingerstick produces an abnormal finding, subsequent testing should generally shift to diagnostic coding (e.g., R73.03 or an appropriate diabetes code) rather than continuing to bill screening.
Although 82962 is typically separately payable from an E/M service, there are important exceptions. Medicare’s NCCI policy specifically addresses PET scans: a fingerstick glucose performed to prepare for a PET study is considered integral and should not be separately reported with 82962 (or 82948) . This is a common denial scenario: clinics or outpatient departments may attempt to bill the glucose check in addition to the PET code, and the glucose line is denied as bundled.
Another bundling risk is duplicate same-day testing across settings: for example, a clinic bills 82962, while a laboratory panel performed the same day includes glucose. Even when both values exist clinically, payers may treat them as duplicative unless documentation shows distinct purpose, timing, and a clinical reason why both were needed. When a payer challenges frequency or duplication, the underlying theme is the same: billing should reflect distinct medically necessary services, not routine redundancy.
Claims hygiene for 82962: Ensure the CLIA number is present, the diagnosis is covered, and the test is not integral to another procedure under NCCI policy. If multiple same-day tests occur, use repeat-test conventions and document timing and rationale .
QW indicates a waived methodology for Medicare billing. CMS guidance clarifies that certain codes, including 82962, are recognized as waived without requiring QW . Practically, that means Medicare payment should not depend on QW for 82962. However, some payer systems or intermediaries may still accept QW and ignore it. The more important compliance element is that the performing site is properly certified and the claim includes the CLIA number.
Use modifier 91 when the same laboratory test is repeated on the same patient on the same day to obtain additional clinical results (not to correct an error or perform quality control). For 82962, this is most common when a second glucose value is needed after treatment, or when monitoring is clinically required during the same date of service. Documentation should show the timing and reason for repeating the test (symptoms persisted, post-treatment confirmation, or a new clinical episode). This aligns with Medicare’s broader principle that repeat testing must be medically necessary and supported by record evidence .
Modifier 59 is used to indicate that two services normally bundled were distinct. For glucose testing, its most defensible use is when two different glucose testing methodologies (or two different contexts) are billed on the same day and there is a legitimate reason for both, such as an immediate fingerstick followed by a confirmatory lab glucose performed later with a different specimen and a different clinical purpose. Medicare billing guidance frequently cautions against using modifiers to bypass edits unless the circumstances truly meet criteria, and supporting documentation is essential . In routine office practice, 59 is not required to bill 82962 alongside an E/M service.
Select the glucose code based on the method and clinical context. The most important distinction is whether testing is performed using a home-use-cleared point-of-care device (82962) versus a laboratory method or a structured glucose tolerance procedure.
| Code | What it represents | Typical setting | Key selection rule |
|---|---|---|---|
| 82962 | Quantitative blood glucose by FDA-cleared home-use monitoring device | Office/clinic point-of-care | Use when a clinic performs a fingerstick glucometer test with a home-use-cleared meter . |
| 82947 / 82948 | Laboratory-style glucose testing (method varies by code) | Laboratory/hospital analyzer workflows | Use when glucose is measured by laboratory method rather than a home-use meter; avoid duplicative billing with 82962 unless clinically justified. |
| 82950 / 82951 | Glucose challenge / glucose tolerance testing procedures | Lab or specialized testing setting | Use for structured tolerance testing; do not replace with multiple 82962 units. Medicare screening guidance commonly focuses on these lab-type codes for diabetes screening workflows . |
If your clinic workflow is “fingerstick in the room for an immediate number,” 82962 is usually the correct code. If your workflow is “venipuncture and lab analyzer,” it is generally not. When both occur, document why both were needed and expect payers to evaluate duplication.
Scenario: Patient with Type 2 diabetes comes for quarterly follow-up; clinic performs a fingerstick glucose using a home-use-cleared meter.
Billing: 82962 plus the appropriate E/M code. Diagnosis: E11.9 (or a more specific diabetes code).
Why it pays: Diagnostic glucose testing for diabetes aligns with NCD 190.20 principles and common payer covered indications .
Scenario: Patient becomes diaphoretic and shaky in clinic; initial fingerstick is low; after oral carbohydrate, repeat glucose confirms improvement.
Billing: 82962 for the first test and 82962-91 for the repeat on the same day. Diagnosis: E16.2 (hypoglycemia) or most specific appropriate diagnosis.
Why it pays: Repeat testing is supported when a new clinical result is necessary for patient care; modifier 91 communicates repeat diagnostic testing .
Scenario: Patient requests diabetes screening; clinic considers a fingerstick test during a preventive visit.
Billing caution: Medicare screening frameworks have specific coding conventions and often emphasize lab-based glucose screening codes; verify benefit rules and correct screening diagnosis reporting before billing. Consider directing the patient to an eligible screening lab test pathway consistent with Medicare screening guidance .
Compliance tip: If screening is likely non-covered, obtain appropriate beneficiary notice and document the screening intent.
Scenario: Fingerstick glucose is performed immediately prior to PET imaging as part of the imaging protocol.
Billing: Do not bill 82962 separately for the PET-related glucose check; it is integral to the imaging service per Medicare NCCI policy .
Scenario: Clinic performs fingerstick glucose for immediate decision, then orders a confirmatory laboratory glucose later the same day due to an unexpected result.
Billing: Avoid routine duplication. If both are billed, document distinct purpose/timing/specimen and consider modifier 59 on the secondary service only when criteria truly apply, recognizing payer scrutiny of modifier usage .
Best practice: When clinically acceptable, separate dates or use a clear confirmatory pathway to reduce “duplicate analyte” denials.
Across all cases, payment success for 82962 is typically driven less by the code itself (which is stable) and more by the supporting claim logic: correct diagnosis, correct CLIA elements, correct modifier selection for repeats, and avoidance of known bundling scenarios.
© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 82962 refers to the process of measuring glucose levels in the blood using a glucose monitoring device that has been specifically cleared by the FDA for home use. This procedure involves the utilization of a portable testing device, commonly known as a glucometer, which can be employed in various settings, including the patient's home or a physician's office. Glucose, a type of monosaccharide or simple sugar, serves as a primary source of energy for the body. Abnormal glucose levels can occur due to various conditions, most notably diabetes, as well as certain medications that may influence glucose metabolism. To perform the test, a small blood sample is typically obtained through a fingerstick method and applied to a chemically treated test strip. The glucometer then measures the electrical current generated by the interaction of the blood with the test strip, which correlates to the glucose concentration in the sample. The resulting glucose level is displayed on the device in milligrams per deciliter (mg/dL). It is important to note that this code is applicable only when the glucose monitoring device is utilized by a healthcare professional in a clinical setting, rather than when the patient conducts the test independently at home.
© Copyright 2026 Coding Ahead. All rights reserved.
The procedure associated with CPT® Code 82962 is indicated for the monitoring of glucose levels in patients who may be experiencing abnormal glucose metabolism. This includes, but is not limited to, the following conditions:
The procedure for CPT® Code 82962 involves several key steps that ensure accurate measurement of blood glucose levels. The following outlines the procedural steps:
After the glucose monitoring procedure is completed, the healthcare professional may provide the patient with immediate feedback regarding their glucose levels. If the levels are outside the normal range, further recommendations may be made, which could include dietary adjustments, medication changes, or additional testing. The healthcare professional should also ensure that the patient understands how to interpret their glucose readings and the importance of regular monitoring. Documentation of the procedure and results should be recorded in the patient's medical record for future reference and continuity of care.
| Short Descr | GLUCOSE BLOOD TEST | Medium Descr | GLUC BLD GLUC MNTR DEV CLEARED FDA SPEC HOME USE | Long Descr | Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | Status Code | Statutory Exclusion (from MPFS, may be paid under other methodologies) | Global Days | XXX - Global Concept Does Not Apply | PC/TC Indicator (26, TC) | 9 - Not Applicable | Multiple Procedures (51) | 9 - Concept does not apply. | Bilateral Surgery (50) | 9 - Concept does not apply. | Physician Supervisions | 09 - Concept does not apply. | Assistant Surgeon (80, 82) | 9 - Concept does not apply. | Co-Surgeons (62) | 9 - Concept does not apply. | Team Surgery (66) | 9 - Concept does not apply. | Diagnostic Imaging Family | 99 - Concept Does Not Apply | CLIA Waived (QW) | No | APC Status Indicator | Conditionally packaged laboratory tests | Type of Service (TOS) | 5 - Diagnostic Laboratory | Berenson-Eggers TOS (BETOS) | T1E - Lab tests - glucose | MUE | 2 | CCS Clinical Classification | 233 - Laboratory - Chemistry and Hematology |
| 59 | Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25. | QW | Clia waived test | GA | Waiver of liability statement issued as required by payer policy, individual case | 91 | Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient. | GZ | Item or service expected to be denied as not reasonable and necessary | GC | This service has been performed in part by a resident under the direction of a teaching physician | GW | Service not related to the hospice patient's terminal condition | XU | Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service | 26 | Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number. | X1 | Continuous/broad services: for reporting services by clinicians, who provide the principal care for a patient, with no planned endpoint of the relationship; services in this category represent comprehensive care, dealing with the entire scope of patient problems, either directly or in a care coordination role; reporting clinician service examples include, but are not limited to: primary care, and clinicians providing comprehensive care to patients in addition to specialty care | GY | Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit | GV | Attending physician not employed or paid under arrangement by the patient's hospice provider | CC | Procedure code change (use 'cc' when the procedure code submitted was changed either for administrative reasons or because an incorrect code was filed) | PO | Excepted service provided at an off-campus, outpatient, provider-based department of a hospital | AQ | Physician providing a service in an unlisted health professional shortage area (hpsa) | SA | Nurse practitioner rendering service in collaboration with a physician | Q6 | Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area | X2 | Continuous/focused services: for reporting services by clinicians whose expertise is needed for the ongoing management of a chronic disease or a condition that needs to be managed and followed with no planned endpoint to the relationship; reporting clinician service examples include but are not limited to: a rheumatologist taking care of the patient's rheumatoid arthritis longitudinally but not providing general primary care services | 95 | Synchronous telemedicine service rendered via a real-time interactive audio and video telecommunications system: synchronous telemedicine service is defined as a real-time interaction between a physician or other qualified health care professional and a patient who is located at a distant site from the physician or other qualified health care professional. the totality of the communication of information exchanged between the physician or other qualified health care professional and the patient during the course of the synchronous telemedicine service must be of an amount and nature that would be sufficient to meet the key components and/or requirements of the same service when rendered via a face-to-face interaction. modifier 95 may only be appended to the services listed in appendix p. appendix p is the list of cpt codes for services that are typically performed face-to-face, but may be rendered via a real-time (synchronous) interactive audio and video telecommunications system. | X4 | Episodic/focused services: for reporting services by clinicians who provide focused care on particular types of treatment limited to a defined period and circumstance; the patient has a problem, acute or chronic, that will be treated with surgery, radiation, or some other type of generally time-limited intervention; reporting clinician service examples include but are not limited to, the orthopedic surgeon performing a knee replacement and seeing the patient through the postoperative period | JZ | Zero drug amount discarded/not administered to any patient | PD | Diagnostic or related non diagnostic item or service provided in a wholly owned or operated entity to a patient who is admitted as an inpatient within 3 days | XS | Separate structure, a service that is distinct because it was performed on a separate organ/structure | 25 | Significant, separately identifiable evaluation and management service by the same physician or other qualified health care professional on the same day of the procedure or other service: it may be necessary to indicate that on the day a procedure or service identified by a cpt code was performed, the patient's condition required a significant, separately identifiable e/m service above and beyond the other service provided or beyond the usual preoperative and postoperative care associated with the procedure that was performed. a significant, separately identifiable e/m service is defined or substantiated by documentation that satisfies the relevant criteria for the respective e/m service to be reported (see evaluation and management services guidelines for instructions on determining level of e/m service). the e/m service may be prompted by the symptom or condition for which the procedure and/or service was provided. as such, different diagnoses are not required for reporting of the e/m services on the same date. this circumstance may be reported by adding modifier 25 to the appropriate level of e/m service. note: this modifier is not used to report an e/m service that resulted in a decision to perform surgery. see modifier 57 for significant, separately identifiable non-e/m services, see modifier 59. | 51 | Multiple procedures: when multiple procedures, other than e/m services, physical medicine and rehabilitation services or provision of supplies (eg, vaccines), are performed at the same session by the same individual, the primary procedure or service may be reported as listed. the additional procedure(s) or service(s) may be identified by appending modifier 51 to the additional procedure or service code(s). note: this modifier should not be appended to designated "add-on" codes (see appendix d). | 56 | Preoperative management only: when 1 physician or other qualified health care professional performed the preoperative care and evaluation and another performed the surgical procedure, the preoperative component may be identified by adding modifier 56 to the usual procedure number. | 58 | Staged or related procedure or service by the same physician or other qualified health care professional during the postoperative period: it may be necessary to indicate that the performance of a procedure or service during the postoperative period was: (a) planned or anticipated (staged); (b) more extensive than the original procedure; or (c) for therapy following a surgical procedure. this circumstance may be reported by adding modifier 58 to the staged or related procedure. note: for treatment of a problem that requires a return to the operating/procedure room (eg, unanticipated clinical condition), see modifier 78. | 76 | Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service. | CA | Procedure payable only in the inpatient setting when performed emergently on an outpatient who expires prior to admission | CG | Policy criteria applied | CR | Catastrophe/disaster related | CS | Cost-sharing waived for specified covid-19 testing-related services that result in and order for or administration of a covid-19 test and/or used for cost-sharing waived preventive services furnished via telehealth in rural health clinics and federally qualified health centers during the covid-19 public health emergency | ET | Emergency services | FP | Service provided as part of family planning program | GE | This service has been performed by a resident without the presence of a teaching physician under the primary care exception | GT | Via interactive audio and video telecommunication systems | GX | Notice of liability issued, voluntary under payer policy | KX | Requirements specified in the medical policy have been met | NB | Nebulizer system, any type, fda-cleared for use with specific drug | PN | Non-excepted service provided at an off-campus, outpatient, provider-based department of a hospital | Q1 | Routine clinical service provided in a clinical research study that is in an approved clinical research study | Q5 | Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area | QJ | Services/items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b) | RT | Right side (used to identify procedures performed on the right side of the body) | SB | Nurse midwife | ST | Related to trauma or injury | U6 | Medicaid level of care 6, as defined by each state | UA | Medicaid level of care 10, as defined by each state | UD | Medicaid level of care 13, as defined by each state | UH | Services provided in the evening | X3 | Episodic/broad services: for reporting services by clinicians who have broad responsibility for the comprehensive needs of the patient that is limited to a defined period and circumstance such as a hospitalization; reporting clinician service examples include but are not limited to the hospitalist's services rendered providing comprehensive and general care to a patient while admitted to the hospital | X5 | Diagnostic services requested by another clinician: for reporting services by a clinician who furnishes care to the patient only as requested by another clinician or subsequent and related services requested by another clinician; this modifier is reported for patient relationships that may not be adequately captured by the above alternative categories; reporting clinician service examples include but are not limited to, the radiologist's interpretation of an imaging study requested by another clinician | XE | Separate encounter, a service that is distinct because it occurred during a separate encounter | XP | Separate practitioner, a service that is distinct because it was performed by a different practitioner |
|
Date
|
Action
|
Notes
|
|---|---|---|
| 1993-01-01 | Added | First appearance in code book in 1993. |
Get instant expert-level medical coding assistance.